Targeted Potassium Levels for Prevention of ICD Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1200 participants.
Also called NCT03833089
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,200 participants
- Registry
-
NCT03833089
-
- Other papers using this trial's data
- Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03833089. Randomized; no masking; primary purpose prevention. Start 2019-03-01 (actual); primary completion 2025-05-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Targeted Potassium Levels for Prevention of ICD Therapy
- Condition
- Ventricular Arrhythmias and Cardiac Arrest
- Condition
- Implantable Defibrillator User
- Condition
- Hypokalemia
- Condition
- Hyperkalemia
- Condition
- Ventricular Tachycardia
- Condition
- Atrial Fibrillation
- Intervention (Combination product)
- Targeted serum potassium level
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Collaborator
- Herlev and Gentofte Hospital
Record details
- Record id
cardio:ct-nct03833089- Content hash
daea5cd22f50ca8b0bbf32b3dbec82410f4dd04daac38060e4738db46e72ef13